

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by symbiont of host defense response (GO:0052509) | 5.85791026 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 5.85791026 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.85791026 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.85791026 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.85791026 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 5.85791026 |
| 7 | glycosphingolipid catabolic process (GO:0046479) | 5.33098552 |
| 8 | eosinophil chemotaxis (GO:0048245) | 5.31513854 |
| 9 | cell adhesion mediated by integrin (GO:0033627) | 5.28695901 |
| 10 | amino sugar catabolic process (GO:0046348) | 5.01246307 |
| 11 | oligosaccharide catabolic process (GO:0009313) | 4.97294197 |
| 12 | glycolipid catabolic process (GO:0019377) | 4.83489575 |
| 13 | cellular response to vitamin D (GO:0071305) | 4.78679565 |
| 14 | eosinophil migration (GO:0072677) | 4.72899454 |
| 15 | neutrophil activation involved in immune response (GO:0002283) | 4.66414396 |
| 16 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.62205702 |
| 17 | ceramide catabolic process (GO:0046514) | 4.48120267 |
| 18 | cellular response to vitamin (GO:0071295) | 4.34610239 |
| 19 | macrophage activation involved in immune response (GO:0002281) | 4.23004000 |
| 20 | cellular extravasation (GO:0045123) | 4.19791732 |
| 21 | macrophage differentiation (GO:0030225) | 4.07476794 |
| 22 | glucosamine-containing compound catabolic process (GO:1901072) | 4.05725740 |
| 23 | barbed-end actin filament capping (GO:0051016) | 4.02916493 |
| 24 | positive regulation of interferon-alpha production (GO:0032727) | 3.99875097 |
| 25 | wound healing, spreading of epidermal cells (GO:0035313) | 3.99265291 |
| 26 | monocyte chemotaxis (GO:0002548) | 3.98569949 |
| 27 | osteoclast differentiation (GO:0030316) | 3.98178431 |
| 28 | phagocytosis, recognition (GO:0006910) | 3.93356813 |
| 29 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.90119031 |
| 30 | cellular response to ethanol (GO:0071361) | 3.89987473 |
| 31 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.88369846 |
| 32 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.87572658 |
| 33 | response to host immune response (GO:0052572) | 3.84865620 |
| 34 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.84865620 |
| 35 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.84014979 |
| 36 | ganglioside metabolic process (GO:0001573) | 3.78061322 |
| 37 | apoptotic cell clearance (GO:0043277) | 3.77511390 |
| 38 | regulation of interferon-alpha production (GO:0032647) | 3.77404275 |
| 39 | microglial cell activation (GO:0001774) | 3.73887759 |
| 40 | regulation of mononuclear cell migration (GO:0071675) | 3.73396352 |
| 41 | cellular response to zinc ion (GO:0071294) | 3.68743080 |
| 42 | negative regulation of leukocyte chemotaxis (GO:0002689) | 3.66754413 |
| 43 | regulation of macrophage chemotaxis (GO:0010758) | 3.64352405 |
| 44 | negative regulation of interleukin-12 production (GO:0032695) | 3.64173433 |
| 45 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.63275304 |
| 46 | response to host (GO:0075136) | 3.63275304 |
| 47 | response to host defenses (GO:0052200) | 3.63275304 |
| 48 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.60283331 |
| 49 | cellular response to cadmium ion (GO:0071276) | 3.56924955 |
| 50 | regulation of hypersensitivity (GO:0002883) | 3.55695833 |
| 51 | response to peptidoglycan (GO:0032494) | 3.53728204 |
| 52 | membrane lipid catabolic process (GO:0046466) | 3.49014706 |
| 53 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.42584223 |
| 54 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.42070439 |
| 55 | collagen catabolic process (GO:0030574) | 3.41956223 |
| 56 | sphingolipid catabolic process (GO:0030149) | 3.41259897 |
| 57 | collagen metabolic process (GO:0032963) | 3.40757066 |
| 58 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.37062884 |
| 59 | peptide catabolic process (GO:0043171) | 3.35764896 |
| 60 | cellular response to interferon-alpha (GO:0035457) | 3.32660013 |
| 61 | chondrocyte proliferation (GO:0035988) | 3.30252836 |
| 62 | keratan sulfate catabolic process (GO:0042340) | 3.26224092 |
| 63 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.24810376 |
| 64 | skin morphogenesis (GO:0043589) | 3.24065622 |
| 65 | endodermal cell differentiation (GO:0035987) | 3.23476356 |
| 66 | adenosine receptor signaling pathway (GO:0001973) | 3.22454652 |
| 67 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.21969196 |
| 68 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 3.21810441 |
| 69 | wound healing, spreading of cells (GO:0044319) | 3.18114363 |
| 70 | collagen fibril organization (GO:0030199) | 3.17990770 |
| 71 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.16864479 |
| 72 | multicellular organismal macromolecule metabolic process (GO:0044259) | 3.14972714 |
| 73 | pinocytosis (GO:0006907) | 3.13731511 |
| 74 | multicellular organismal catabolic process (GO:0044243) | 3.13418424 |
| 75 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.12029042 |
| 76 | * granulocyte chemotaxis (GO:0071621) | 3.10195504 |
| 77 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.09530871 |
| 78 | * response to vitamin D (GO:0033280) | 3.09455136 |
| 79 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.09261706 |
| 80 | phagosome maturation (GO:0090382) | 3.08329534 |
| 81 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.04533616 |
| 82 | regulation of monocyte chemotaxis (GO:0090025) | 3.02719201 |
| 83 | multicellular organismal metabolic process (GO:0044236) | 2.99313800 |
| 84 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.99118864 |
| 85 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.98686686 |
| 86 | macrophage activation (GO:0042116) | 2.97024857 |
| 87 | * granulocyte migration (GO:0097530) | 2.96879726 |
| 88 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.96657723 |
| 89 | myeloid cell homeostasis (GO:0002262) | 2.95574507 |
| 90 | positive regulation of heat generation (GO:0031652) | 2.93802537 |
| 91 | N-acetylneuraminate metabolic process (GO:0006054) | 2.93799584 |
| 92 | positive regulation of antigen processing and presentation (GO:0002579) | 2.93159218 |
| 93 | response to interferon-alpha (GO:0035455) | 2.92085524 |
| 94 | positive regulation of mast cell degranulation (GO:0043306) | 2.92024404 |
| 95 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.92024404 |
| 96 | low-density lipoprotein particle clearance (GO:0034383) | 2.91433037 |
| 97 | * extracellular matrix disassembly (GO:0022617) | 2.90913405 |
| 98 | positive regulation of leukocyte degranulation (GO:0043302) | 2.89902725 |
| 99 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.89288198 |
| 100 | negative regulation of fatty acid transport (GO:2000192) | 2.88692088 |
| 101 | COPI coating of Golgi vesicle (GO:0048205) | 2.87979827 |
| 102 | Golgi transport vesicle coating (GO:0048200) | 2.87979827 |
| 103 | positive regulation of mast cell activation (GO:0033005) | 2.85830437 |
| 104 | cytidine catabolic process (GO:0006216) | 2.85352050 |
| 105 | cytidine deamination (GO:0009972) | 2.85352050 |
| 106 | cytidine metabolic process (GO:0046087) | 2.85352050 |
| 107 | * decidualization (GO:0046697) | 2.85112334 |
| 108 | cellular response to nutrient (GO:0031670) | 2.84029257 |
| 109 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.83870382 |
| 110 | regulation of cholesterol storage (GO:0010885) | 2.83416762 |
| 111 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 2.83366402 |
| 112 | myeloid cell activation involved in immune response (GO:0002275) | 2.83214715 |
| 113 | I-kappaB phosphorylation (GO:0007252) | 2.82885337 |
| 114 | positive regulation of chemokine secretion (GO:0090197) | 2.82676258 |
| 115 | iron ion import (GO:0097286) | 2.80396937 |
| 116 | regulation of fever generation (GO:0031620) | 2.79679764 |
| 117 | superoxide anion generation (GO:0042554) | 2.78270923 |
| 118 | positive regulation of macrophage cytokine production (GO:0060907) | 2.77736289 |
| 119 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.77681710 |
| 120 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.77419677 |
| 121 | histamine secretion (GO:0001821) | 2.76897717 |
| 122 | intracellular pH reduction (GO:0051452) | 2.76545396 |
| 123 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.76107487 |
| 124 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.75748891 |
| 125 | negative regulation of biomineral tissue development (GO:0070168) | 2.75345680 |
| 126 | positive regulation of p38MAPK cascade (GO:1900745) | 2.74492438 |
| 127 | * positive regulation of bone resorption (GO:0045780) | 2.74213372 |
| 128 | * positive regulation of bone remodeling (GO:0046852) | 2.74213372 |
| 129 | hyaluronan catabolic process (GO:0030214) | 2.74111754 |
| 130 | adhesion of symbiont to host cell (GO:0044650) | 2.73979470 |
| 131 | virion attachment to host cell (GO:0019062) | 2.73979470 |
| 132 | detection of molecule of bacterial origin (GO:0032490) | 2.73565346 |
| 133 | respiratory burst (GO:0045730) | 2.73262004 |
| 134 | * positive regulation of tissue remodeling (GO:0034105) | 2.72814241 |
| 135 | glucose 6-phosphate metabolic process (GO:0051156) | 2.72610316 |
| 136 | * neutrophil chemotaxis (GO:0030593) | 2.71991864 |
| 137 | NADPH regeneration (GO:0006740) | 2.71923687 |
| 138 | immunoglobulin mediated immune response (GO:0016064) | 2.70314352 |
| 139 | regulation of monocyte differentiation (GO:0045655) | 2.68833022 |
| 140 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.68208916 |
| 141 | myeloid dendritic cell differentiation (GO:0043011) | 2.68183714 |
| 142 | substrate-dependent cell migration (GO:0006929) | 2.67794026 |
| 143 | positive regulation of interferon-beta production (GO:0032728) | 2.67650110 |
| 144 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.66763056 |
| 145 | negative regulation of lipid storage (GO:0010888) | 2.66266234 |
| 146 | positive regulation of acute inflammatory response (GO:0002675) | 2.66083410 |
| 147 | regulation of macrophage cytokine production (GO:0010935) | 2.65515132 |
| 148 | response to thyroid hormone (GO:0097066) | 2.65429911 |
| 149 | * neutrophil migration (GO:1990266) | 2.65261837 |
| 150 | transferrin transport (GO:0033572) | 2.65192313 |
| 151 | response to muramyl dipeptide (GO:0032495) | 2.64584950 |
| 152 | protein heterotrimerization (GO:0070208) | 2.64578981 |
| 153 | pH reduction (GO:0045851) | 2.63862634 |
| 154 | ruffle organization (GO:0031529) | 2.63655708 |
| 155 | T-helper 1 type immune response (GO:0042088) | 2.63581921 |
| 156 | negative regulation of mast cell activation (GO:0033004) | 2.63444723 |
| 157 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.62889853 |
| 158 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.62814365 |
| 159 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.62519938 |
| 160 | positive regulation of phagocytosis (GO:0050766) | 2.61901155 |
| 161 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.59922584 |
| 162 | natural killer cell mediated immunity (GO:0002228) | 2.59922584 |
| 163 | regulation of prostaglandin secretion (GO:0032306) | 2.59771808 |
| 164 | adhesion of symbiont to host (GO:0044406) | 2.58944170 |
| 165 | response to manganese ion (GO:0010042) | 2.58434778 |
| 166 | endothelial cell morphogenesis (GO:0001886) | 2.57409033 |
| 167 | negative regulation of bone mineralization (GO:0030502) | 2.57152450 |
| 168 | * myeloid leukocyte migration (GO:0097529) | 2.57098036 |
| 169 | negative regulation of interleukin-17 production (GO:0032700) | 2.57048964 |
| 170 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.55814839 |
| 171 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.55478846 |
| 172 | axon extension involved in axon guidance (GO:0048846) | 2.55478846 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.82394663 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.55193720 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.35416551 |
| 4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.89527701 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.70802145 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.54249684 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.51015598 |
| 8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.49362191 |
| 9 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.41195481 |
| 10 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.39572564 |
| 11 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.02575686 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.96582733 |
| 13 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.87780187 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.78239555 |
| 15 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.59834545 |
| 16 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.57007526 |
| 17 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.39232535 |
| 18 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.36320911 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.33162921 |
| 20 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.27176351 |
| 21 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.24530183 |
| 22 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.14039665 |
| 23 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 2.05957259 |
| 24 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.03601058 |
| 25 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.02357381 |
| 26 | CJUN_26792858_Chip-Seq_BT549_Human | 1.96319138 |
| 27 | GATA1_22025678_ChIP-Seq_K562_Human | 1.94266226 |
| 28 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.92108627 |
| 29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.90929266 |
| 30 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.90210879 |
| 31 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.90210879 |
| 32 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.82360848 |
| 33 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.80779464 |
| 34 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.80205898 |
| 35 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.79794940 |
| 36 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.79794940 |
| 37 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.77812212 |
| 38 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.77790519 |
| 39 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.72702596 |
| 40 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.71606100 |
| 41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.70622459 |
| 42 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.64926039 |
| 43 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.62336916 |
| 44 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.61355986 |
| 45 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.60116870 |
| 46 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.56087638 |
| 47 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.50753758 |
| 48 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.49687892 |
| 49 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.49185961 |
| 50 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.45563091 |
| 51 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.41593416 |
| 52 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.41082951 |
| 53 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.40455455 |
| 54 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.40057369 |
| 55 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.36712750 |
| 56 | ATF3_27146783_Chip-Seq_COLON_Human | 1.35429564 |
| 57 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.34608824 |
| 58 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.32519760 |
| 59 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30551621 |
| 60 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.30101017 |
| 61 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29066831 |
| 62 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25457103 |
| 63 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.24879827 |
| 64 | * NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.24306828 |
| 65 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.23917638 |
| 66 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.23544395 |
| 67 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.23355137 |
| 68 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22965392 |
| 69 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22079898 |
| 70 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21935298 |
| 71 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.19168120 |
| 72 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18802490 |
| 73 | * POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.18721148 |
| 74 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18442790 |
| 75 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.17592592 |
| 76 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.16558948 |
| 77 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.16135754 |
| 78 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14836041 |
| 79 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.14047727 |
| 80 | TP53_16413492_ChIP-PET_HCT116_Human | 1.13749931 |
| 81 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13463365 |
| 82 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.12659005 |
| 83 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09508561 |
| 84 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09395103 |
| 85 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.09369349 |
| 86 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.08090722 |
| 87 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.06769531 |
| 88 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.06709614 |
| 89 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.05851981 |
| 90 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05568827 |
| 91 | SPI1_23127762_ChIP-Seq_K562_Human | 1.04730542 |
| 92 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.04722157 |
| 93 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.03680291 |
| 94 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03496917 |
| 95 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.02996908 |
| 96 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01921752 |
| 97 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.01124130 |
| 98 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.01029718 |
| 99 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.00632132 |
| 100 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.00575728 |
| 101 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00426415 |
| 102 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.00052191 |
| 103 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.99656695 |
| 104 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.98902338 |
| 105 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98611979 |
| 106 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98603537 |
| 107 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.98316519 |
| 108 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98160076 |
| 109 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.96790001 |
| 110 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.96549774 |
| 111 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.95472969 |
| 112 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.94126951 |
| 113 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94007601 |
| 114 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.93903911 |
| 115 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.93545607 |
| 116 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.93166092 |
| 117 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.91427706 |
| 118 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.90656905 |
| 119 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.89895361 |
| 120 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.89429179 |
| 121 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87288299 |
| 122 | GATA1_19941826_ChIP-Seq_K562_Human | 0.85586815 |
| 123 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.84272586 |
| 124 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.83056222 |
| 125 | MYB_26560356_Chip-Seq_TH2_Human | 0.82946160 |
| 126 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82745049 |
| 127 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.81890649 |
| 128 | KDM2B_26808549_Chip-Seq_K562_Human | 0.81889676 |
| 129 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.80298989 |
| 130 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.80284163 |
| 131 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.80213262 |
| 132 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.80198352 |
| 133 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.79357807 |
| 134 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.76844366 |
| 135 | GATA2_19941826_ChIP-Seq_K562_Human | 0.74584581 |
| 136 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.73779058 |
| 137 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.72440980 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 5.09755138 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.83711192 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.45673498 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 3.22560808 |
| 5 | MP0003436_decreased_susceptibility_to | 2.91614159 |
| 6 | MP0005167_abnormal_blood-brain_barrier | 2.75620353 |
| 7 | MP0005275_abnormal_skin_tensile | 2.66681764 |
| 8 | MP0001958_emphysema | 2.57338304 |
| 9 | MP0005503_abnormal_tendon_morphology | 2.52638940 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.51670742 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.44913872 |
| 12 | MP0003279_aneurysm | 2.36838172 |
| 13 | MP0003303_peritoneal_inflammation | 2.34884367 |
| 14 | MP0003566_abnormal_cell_adhesion | 2.30339609 |
| 15 | MP0010352_gastrointestinal_tract_polyps | 2.25681074 |
| 16 | MP0006082_CNS_inflammation | 2.18117290 |
| 17 | MP0001533_abnormal_skeleton_physiology | 2.14984857 |
| 18 | * MP0005023_abnormal_wound_healing | 2.12706520 |
| 19 | MP0003329_amyloid_beta_deposits | 2.05645243 |
| 20 | MP0005257_abnormal_intraocular_pressure | 2.04694146 |
| 21 | MP0005671_abnormal_response_to | 1.90709193 |
| 22 | MP0010386_abnormal_urinary_bladder | 1.87315034 |
| 23 | MP0000920_abnormal_myelination | 1.84177497 |
| 24 | MP0003448_altered_tumor_morphology | 1.83092143 |
| 25 | * MP0002419_abnormal_innate_immunity | 1.81965382 |
| 26 | MP0001542_abnormal_bone_strength | 1.79019761 |
| 27 | * MP0002998_abnormal_bone_remodeling | 1.78828707 |
| 28 | MP0006054_spinal_hemorrhage | 1.76632553 |
| 29 | MP0004272_abnormal_basement_membrane | 1.72409188 |
| 30 | MP0010307_abnormal_tumor_latency | 1.69476317 |
| 31 | * MP0000343_altered_response_to | 1.65292214 |
| 32 | MP0002933_joint_inflammation | 1.64650814 |
| 33 | MP0000604_amyloidosis | 1.62865067 |
| 34 | MP0009840_abnormal_foam_cell | 1.61696581 |
| 35 | MP0005365_abnormal_bile_salt | 1.60487821 |
| 36 | MP0010234_abnormal_vibrissa_follicle | 1.60062269 |
| 37 | MP0000858_altered_metastatic_potential | 1.59650254 |
| 38 | MP0005390_skeleton_phenotype | 1.55810364 |
| 39 | MP0000685_abnormal_immune_system | 1.55789882 |
| 40 | * MP0002148_abnormal_hypersensitivity_rea | 1.51022280 |
| 41 | MP0009384_cardiac_valve_regurgitation | 1.49638423 |
| 42 | * MP0009785_altered_susceptibility_to | 1.49548471 |
| 43 | * MP0003091_abnormal_cell_migration | 1.48262615 |
| 44 | MP0001835_abnormal_antigen_presentation | 1.45402880 |
| 45 | MP0002295_abnormal_pulmonary_circulatio | 1.45096919 |
| 46 | * MP0002896_abnormal_bone_mineralization | 1.44675696 |
| 47 | MP0003828_pulmonary_edema | 1.43973071 |
| 48 | MP0005310_abnormal_salivary_gland | 1.42378565 |
| 49 | * MP0005000_abnormal_immune_tolerance | 1.40136426 |
| 50 | MP0005076_abnormal_cell_differentiation | 1.39818830 |
| 51 | MP0003806_abnormal_nucleotide_metabolis | 1.37619159 |
| 52 | * MP0001545_abnormal_hematopoietic_system | 1.37243262 |
| 53 | * MP0005397_hematopoietic_system_phenotyp | 1.37243262 |
| 54 | * MP0003795_abnormal_bone_structure | 1.35834796 |
| 55 | MP0000750_abnormal_muscle_regeneration | 1.33167303 |
| 56 | MP0001881_abnormal_mammary_gland | 1.33027433 |
| 57 | MP0005623_abnormal_meninges_morphology | 1.32994164 |
| 58 | MP0005379_endocrine/exocrine_gland_phen | 1.32703346 |
| 59 | MP0003045_fibrosis | 1.32677149 |
| 60 | MP0005451_abnormal_body_composition | 1.32457579 |
| 61 | MP0003656_abnormal_erythrocyte_physiolo | 1.30929150 |
| 62 | MP0003075_altered_response_to | 1.30335603 |
| 63 | MP0005166_decreased_susceptibility_to | 1.29624289 |
| 64 | MP0001800_abnormal_humoral_immune | 1.28475678 |
| 65 | MP0008260_abnormal_autophagy | 1.28381982 |
| 66 | MP0004947_skin_inflammation | 1.28106722 |
| 67 | MP0002277_abnormal_respiratory_mucosa | 1.27218383 |
| 68 | * MP0005164_abnormal_response_to | 1.27135480 |
| 69 | * MP0003195_calcinosis | 1.25309598 |
| 70 | MP0002138_abnormal_hepatobiliary_system | 1.25069026 |
| 71 | MP0003191_abnormal_cellular_cholesterol | 1.24872053 |
| 72 | MP0003690_abnormal_glial_cell | 1.22629386 |
| 73 | MP0002877_abnormal_melanocyte_morpholog | 1.22112150 |
| 74 | * MP0002168_other_aberrant_phenotype | 1.21739657 |
| 75 | MP0003453_abnormal_keratinocyte_physiol | 1.21524796 |
| 76 | MP0005508_abnormal_skeleton_morphology | 1.21165668 |
| 77 | MP0002837_dystrophic_cardiac_calcinosis | 1.18171340 |
| 78 | * MP0009278_abnormal_bone_marrow | 1.14826192 |
| 79 | MP0009764_decreased_sensitivity_to | 1.12717869 |
| 80 | * MP0005025_abnormal_response_to | 1.11547449 |
| 81 | MP0003283_abnormal_digestive_organ | 1.11069956 |
| 82 | MP0002115_abnormal_skeleton_extremities | 1.10624952 |
| 83 | * MP0002452_abnormal_antigen_presenting | 1.10589307 |
| 84 | MP0002163_abnormal_gland_morphology | 1.09406929 |
| 85 | MP0002060_abnormal_skin_morphology | 1.06000908 |
| 86 | MP0000569_abnormal_digit_pigmentation | 1.04300212 |
| 87 | MP0005197_abnormal_uvea_morphology | 1.02570858 |
| 88 | * MP0004883_abnormal_blood_vessel | 0.99529026 |
| 89 | MP0000733_abnormal_muscle_development | 0.98407380 |
| 90 | * MP0003634_abnormal_glial_cell | 0.98398822 |
| 91 | MP0002113_abnormal_skeleton_development | 0.97790347 |
| 92 | * MP0001845_abnormal_inflammatory_respons | 0.96939889 |
| 93 | MP0000371_diluted_coat_color | 0.96114569 |
| 94 | MP0005647_abnormal_sex_gland | 0.95022048 |
| 95 | MP0005464_abnormal_platelet_physiology | 0.94230474 |
| 96 | * MP0002136_abnormal_kidney_physiology | 0.93115123 |
| 97 | MP0002405_respiratory_system_inflammati | 0.91459459 |
| 98 | MP0001853_heart_inflammation | 0.90621532 |
| 99 | MP0000767_abnormal_smooth_muscle | 0.89858516 |
| 100 | MP0000627_abnormal_mammary_gland | 0.89363327 |
| 101 | MP0001243_abnormal_dermal_layer | 0.88777896 |
| 102 | MP0003633_abnormal_nervous_system | 0.87434374 |
| 103 | * MP0008469_abnormal_protein_level | 0.87039666 |
| 104 | MP0001915_intracranial_hemorrhage | 0.85903913 |
| 105 | MP0005083_abnormal_biliary_tract | 0.85637414 |
| 106 | MP0003183_abnormal_peptide_metabolism | 0.85416571 |
| 107 | MP0000163_abnormal_cartilage_morphology | 0.84257392 |
| 108 | MP0002090_abnormal_vision | 0.82533122 |
| 109 | MP0001849_ear_inflammation | 0.81451182 |
| 110 | MP0004510_myositis | 0.80891878 |
| 111 | MP0002282_abnormal_trachea_morphology | 0.80312519 |
| 112 | * MP0002135_abnormal_kidney_morphology | 0.80135476 |
| 113 | * MP0005595_abnormal_vascular_smooth | 0.79550811 |
| 114 | * MP0000249_abnormal_blood_vessel | 0.78180292 |
| 115 | * MP0002723_abnormal_immune_serum | 0.77121616 |
| 116 | MP0004019_abnormal_vitamin_homeostasis | 0.76272629 |
| 117 | MP0010155_abnormal_intestine_physiology | 0.76246419 |
| 118 | MP0001756_abnormal_urination | 0.75716025 |
| 119 | * MP0009643_abnormal_urine_homeostasis | 0.75577306 |
| 120 | * MP0009763_increased_sensitivity_to | 0.74164823 |
| 121 | * MP0001790_abnormal_immune_system | 0.73971613 |
| 122 | * MP0005387_immune_system_phenotype | 0.73971613 |
| 123 | MP0003186_abnormal_redox_activity | 0.73715098 |
| 124 | MP0010678_abnormal_skin_adnexa | 0.73063104 |
| 125 | MP0001299_abnormal_eye_distance/ | 0.73021653 |
| 126 | * MP0001819_abnormal_immune_cell | 0.72406689 |
| 127 | * MP0002420_abnormal_adaptive_immunity | 0.71141319 |
| 128 | MP0003950_abnormal_plasma_membrane | 0.70493788 |
| 129 | MP0008004_abnormal_stomach_pH | 0.70350077 |
| 130 | * MP0000716_abnormal_immune_system | 0.68942671 |
| 131 | MP0009333_abnormal_splenocyte_physiolog | 0.68098576 |
| 132 | * MP0005165_increased_susceptibility_to | 0.67724211 |
| 133 | MP0003632_abnormal_nervous_system | 0.67709429 |
| 134 | MP0003724_increased_susceptibility_to | 0.67215144 |
| 135 | MP0003631_nervous_system_phenotype | 0.65603651 |
| 136 | MP0002254_reproductive_system_inflammat | 0.63724999 |
| 137 | MP0001851_eye_inflammation | 0.63689098 |
| 138 | MP0003252_abnormal_bile_duct | 0.62375128 |
| 139 | MP0005171_absent_coat_pigmentation | 0.58711811 |
| 140 | MP0004233_abnormal_muscle_weight | 0.57210667 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased cerebral lipofuscin (HP:0011813) | 5.03725452 |
| 2 | Vacuolated lymphocytes (HP:0001922) | 4.87764602 |
| 3 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.67520182 |
| 4 | Protrusio acetabuli (HP:0003179) | 4.61000178 |
| 5 | Premature rupture of membranes (HP:0001788) | 4.56424019 |
| 6 | Mutism (HP:0002300) | 4.52517546 |
| 7 | Cervical subluxation (HP:0003308) | 4.19600598 |
| 8 | Dysostosis multiplex (HP:0000943) | 4.17139986 |
| 9 | Neurofibrillary tangles (HP:0002185) | 3.85887039 |
| 10 | Vertebral compression fractures (HP:0002953) | 3.81893351 |
| 11 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.68555388 |
| 12 | Mucopolysacchariduria (HP:0008155) | 3.68555388 |
| 13 | Axonal loss (HP:0003447) | 3.60836408 |
| 14 | Upper motor neuron abnormality (HP:0002127) | 3.56039689 |
| 15 | Metaphyseal irregularity (HP:0003025) | 3.55203706 |
| 16 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.39370659 |
| 17 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.39370659 |
| 18 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.39370659 |
| 19 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.34219571 |
| 20 | Complement deficiency (HP:0004431) | 3.33571522 |
| 21 | Disinhibition (HP:0000734) | 3.31512373 |
| 22 | Abnormality of glycolipid metabolism (HP:0010969) | 3.30211290 |
| 23 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.30211290 |
| 24 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.30211290 |
| 25 | Mediastinal lymphadenopathy (HP:0100721) | 3.24806255 |
| 26 | Metaphyseal cupping (HP:0003021) | 3.23862867 |
| 27 | Eczematoid dermatitis (HP:0000976) | 3.13251675 |
| 28 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.07660783 |
| 29 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.06144030 |
| 30 | Osteolytic defects of the hand bones (HP:0009699) | 3.06144030 |
| 31 | Systemic lupus erythematosus (HP:0002725) | 3.01553022 |
| 32 | Recurrent abscess formation (HP:0002722) | 2.97876086 |
| 33 | Nuclear cataract (HP:0100018) | 2.89626374 |
| 34 | Ankle contracture (HP:0006466) | 2.89474248 |
| 35 | Amyloidosis (HP:0011034) | 2.85992880 |
| 36 | Abnormality of macrophages (HP:0004311) | 2.84330367 |
| 37 | Beaking of vertebral bodies (HP:0004568) | 2.80544967 |
| 38 | Spondylolisthesis (HP:0003302) | 2.77692692 |
| 39 | Atrophic scars (HP:0001075) | 2.75943238 |
| 40 | Peritonitis (HP:0002586) | 2.72786151 |
| 41 | Cerebral inclusion bodies (HP:0100314) | 2.71178225 |
| 42 | Cerebral aneurysm (HP:0004944) | 2.69146949 |
| 43 | Aortic dissection (HP:0002647) | 2.68557226 |
| 44 | Myocardial infarction (HP:0001658) | 2.68229379 |
| 45 | Soft skin (HP:0000977) | 2.64942265 |
| 46 | Arterial tortuosity (HP:0005116) | 2.63464474 |
| 47 | Neuronal loss in central nervous system (HP:0002529) | 2.63109399 |
| 48 | Wormian bones (HP:0002645) | 2.57896870 |
| 49 | Pathologic fracture (HP:0002756) | 2.56996319 |
| 50 | Xanthomatosis (HP:0000991) | 2.56585279 |
| 51 | Vascular tortuosity (HP:0004948) | 2.54105655 |
| 52 | Aortic aneurysm (HP:0004942) | 2.49730084 |
| 53 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.48412164 |
| 54 | Recurrent skin infections (HP:0001581) | 2.45519866 |
| 55 | Persistence of primary teeth (HP:0006335) | 2.39052612 |
| 56 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.39042748 |
| 57 | Coxa vara (HP:0002812) | 2.38428668 |
| 58 | Cupped ribs (HP:0000887) | 2.38397910 |
| 59 | Recurrent bacterial skin infections (HP:0005406) | 2.37959036 |
| 60 | Inappropriate behavior (HP:0000719) | 2.37844387 |
| 61 | Bone pain (HP:0002653) | 2.37574761 |
| 62 | Abnormality of complement system (HP:0005339) | 2.34461091 |
| 63 | Blue sclerae (HP:0000592) | 2.34356452 |
| 64 | Ovoid vertebral bodies (HP:0003300) | 2.33514264 |
| 65 | Basal ganglia calcification (HP:0002135) | 2.31852980 |
| 66 | Hepatosplenomegaly (HP:0001433) | 2.30774726 |
| 67 | Abnormality of the lumbar spine (HP:0100712) | 2.30481310 |
| 68 | Hydroxyprolinuria (HP:0003080) | 2.28594084 |
| 69 | Abnormality of proline metabolism (HP:0010907) | 2.28594084 |
| 70 | Retinal atrophy (HP:0001105) | 2.28531218 |
| 71 | Global brain atrophy (HP:0002283) | 2.26887483 |
| 72 | Dementia (HP:0000726) | 2.26258334 |
| 73 | Hypoplasia of the odontoid process (HP:0003311) | 2.25806720 |
| 74 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.25428777 |
| 75 | Ulnar bowing (HP:0003031) | 2.25015863 |
| 76 | Progressive visual loss (HP:0000529) | 2.24423814 |
| 77 | Purpura (HP:0000979) | 2.23634721 |
| 78 | Loss of speech (HP:0002371) | 2.21813798 |
| 79 | Fragile skin (HP:0001030) | 2.20953338 |
| 80 | Tetraparesis (HP:0002273) | 2.20506288 |
| 81 | Personality changes (HP:0000751) | 2.20425188 |
| 82 | Platyspondyly (HP:0000926) | 2.20049450 |
| 83 | Shallow orbits (HP:0000586) | 2.19974915 |
| 84 | Absent frontal sinuses (HP:0002688) | 2.19646613 |
| 85 | Genu recurvatum (HP:0002816) | 2.19107405 |
| 86 | Mitral stenosis (HP:0001718) | 2.19099247 |
| 87 | Dilatation of the ascending aorta (HP:0005111) | 2.18669207 |
| 88 | Progressive neurologic deterioration (HP:0002344) | 2.17570064 |
| 89 | Increased CSF protein (HP:0002922) | 2.17253893 |
| 90 | Abnormality of the odontoid process (HP:0003310) | 2.15285702 |
| 91 | Interstitial pulmonary disease (HP:0006530) | 2.14730539 |
| 92 | Glomerulonephritis (HP:0000099) | 2.13522996 |
| 93 | Esophageal neoplasm (HP:0100751) | 2.13117734 |
| 94 | Neoplasm of head and neck (HP:0012288) | 2.13117734 |
| 95 | Femoral bowing (HP:0002980) | 2.12376348 |
| 96 | Abnormality of the periventricular white matter (HP:0002518) | 2.11719329 |
| 97 | Cardiomegaly (HP:0001640) | 2.11424439 |
| 98 | Biconcave vertebral bodies (HP:0004586) | 2.11035891 |
| 99 | Spontaneous hematomas (HP:0007420) | 2.10878822 |
| 100 | Lymphangioma (HP:0100764) | 2.10085803 |
| 101 | Joint stiffness (HP:0001387) | 2.09896042 |
| 102 | Prolonged neonatal jaundice (HP:0006579) | 2.09233692 |
| 103 | Abnormality of the acetabulum (HP:0003170) | 2.08643865 |
| 104 | Diminished motivation (HP:0000745) | 2.05897283 |
| 105 | Hypophosphatemia (HP:0002148) | 2.04362930 |
| 106 | Thin bony cortex (HP:0002753) | 2.03925696 |
| 107 | Apathy (HP:0000741) | 2.03306044 |
| 108 | Increased density of long bones (HP:0006392) | 2.00431927 |
| 109 | Esophageal varix (HP:0002040) | 1.99064491 |
| 110 | Exostoses (HP:0100777) | 1.96764964 |
| 111 | Tibial bowing (HP:0002982) | 1.96422713 |
| 112 | Peripheral demyelination (HP:0011096) | 1.95531695 |
| 113 | Autoimmune thrombocytopenia (HP:0001973) | 1.95073111 |
| 114 | Increased serum ferritin (HP:0003281) | 1.92895070 |
| 115 | Cardiovascular calcification (HP:0011915) | 1.92387492 |
| 116 | J-shaped sella turcica (HP:0002680) | 1.91740675 |
| 117 | Prostate neoplasm (HP:0100787) | 1.89895505 |
| 118 | Recurrent pneumonia (HP:0006532) | 1.89777978 |
| 119 | Follicular hyperkeratosis (HP:0007502) | 1.87515959 |
| 120 | Radial bowing (HP:0002986) | 1.87460987 |
| 121 | Abnormal cartilage morphology (HP:0002763) | 1.87375618 |
| 122 | Asymmetric septal hypertrophy (HP:0001670) | 1.87206566 |
| 123 | Poor head control (HP:0002421) | 1.86258851 |
| 124 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.86078554 |
| 125 | Agnosia (HP:0010524) | 1.85964317 |
| 126 | Neonatal short-limb short stature (HP:0008921) | 1.85942683 |
| 127 | Obstructive lung disease (HP:0006536) | 1.85817517 |
| 128 | Chronic obstructive pulmonary disease (HP:0006510) | 1.85817517 |
| 129 | Nephritis (HP:0000123) | 1.85810905 |
| 130 | Pustule (HP:0200039) | 1.85780362 |
| 131 | Osteomyelitis (HP:0002754) | 1.85779041 |
| 132 | Gingivitis (HP:0000230) | 1.84196984 |
| 133 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.82726775 |
| 134 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.82269761 |
| 135 | Hematochezia (HP:0002573) | 1.79856095 |
| 136 | Thoracic kyphosis (HP:0002942) | 1.79620693 |
| 137 | Multiple enchondromatosis (HP:0005701) | 1.79324333 |
| 138 | Bladder diverticulum (HP:0000015) | 1.79207394 |
| 139 | Malnutrition (HP:0004395) | 1.78229591 |
| 140 | Protuberant abdomen (HP:0001538) | 1.78149742 |
| 141 | Spinal cord lesions (HP:0100561) | 1.78116263 |
| 142 | Syringomyelia (HP:0003396) | 1.78116263 |
| 143 | Mitral valve prolapse (HP:0001634) | 1.76843136 |
| 144 | Azoospermia (HP:0000027) | 1.76597105 |
| 145 | Spinal muscular atrophy (HP:0007269) | 1.72904349 |
| 146 | Supranuclear gaze palsy (HP:0000605) | 1.72813956 |
| 147 | Irregular vertebral endplates (HP:0003301) | 1.71790611 |
| 148 | Premature loss of primary teeth (HP:0006323) | 1.69676850 |
| 149 | Recurrent fungal infections (HP:0002841) | 1.69090968 |
| 150 | Bone cyst (HP:0012062) | 1.68580398 |
| 151 | Memory impairment (HP:0002354) | 1.67605369 |
| 152 | Petechiae (HP:0000967) | 1.66884038 |
| 153 | Conjunctival telangiectasia (HP:0000524) | 1.66764982 |
| 154 | Impaired platelet aggregation (HP:0003540) | 1.65542502 |
| 155 | Abnormal platelet function (HP:0011869) | 1.65542502 |
| 156 | Hypercholesterolemia (HP:0003124) | 1.64580628 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LMTK2 | 4.87630603 |
| 2 | IRAK3 | 3.84011264 |
| 3 | DDR2 | 3.23524568 |
| 4 | ERN1 | 3.02568145 |
| 5 | PKN2 | 2.88397355 |
| 6 | PBK | 2.86807907 |
| 7 | NME2 | 2.80907782 |
| 8 | TRIB3 | 2.68857981 |
| 9 | TTN | 2.58736169 |
| 10 | TBK1 | 2.54443038 |
| 11 | EPHA2 | 2.26576853 |
| 12 | KIT | 2.25569980 |
| 13 | SCYL2 | 2.19756421 |
| 14 | TGFBR2 | 2.15916479 |
| 15 | PDGFRA | 2.02536841 |
| 16 | LRRK2 | 2.01985454 |
| 17 | FGR | 1.92640306 |
| 18 | PAK4 | 1.92141324 |
| 19 | PIM2 | 1.91800021 |
| 20 | FRK | 1.80083658 |
| 21 | TYK2 | 1.75619555 |
| 22 | GRK7 | 1.73155307 |
| 23 | NEK9 | 1.67873572 |
| 24 | MAP3K3 | 1.66665359 |
| 25 | EPHB1 | 1.63489926 |
| 26 | RIPK1 | 1.59508408 |
| 27 | EPHA3 | 1.49289766 |
| 28 | BMX | 1.49039326 |
| 29 | RPS6KA4 | 1.46354058 |
| 30 | STK10 | 1.43349093 |
| 31 | MOS | 1.42475977 |
| 32 | MAP3K14 | 1.39057206 |
| 33 | PTK6 | 1.34010284 |
| 34 | TRPM7 | 1.33601031 |
| 35 | FER | 1.31431471 |
| 36 | TESK1 | 1.25218264 |
| 37 | CAMK1D | 1.24203131 |
| 38 | MST1R | 1.22359910 |
| 39 | ABL2 | 1.21686842 |
| 40 | BLK | 1.20911954 |
| 41 | CDK6 | 1.20244726 |
| 42 | STK3 | 1.19680643 |
| 43 | DYRK1B | 1.17385304 |
| 44 | JAK1 | 1.16567205 |
| 45 | ERBB3 | 1.13839692 |
| 46 | CDC42BPA | 1.13329997 |
| 47 | MATK | 1.11160550 |
| 48 | MST4 | 1.08919393 |
| 49 | WNK4 | 1.06325994 |
| 50 | PDGFRB | 1.03766993 |
| 51 | JAK3 | 1.00869993 |
| 52 | IKBKB | 1.00729228 |
| 53 | RIPK4 | 1.00658431 |
| 54 | PTK2 | 0.96330200 |
| 55 | MET | 0.95329711 |
| 56 | CAMKK2 | 0.94674350 |
| 57 | LATS1 | 0.94396756 |
| 58 | MAP2K3 | 0.94182668 |
| 59 | ADRBK2 | 0.94162794 |
| 60 | PLK2 | 0.92017091 |
| 61 | SIK1 | 0.91521932 |
| 62 | ZAP70 | 0.88661350 |
| 63 | ERBB4 | 0.88199673 |
| 64 | CHUK | 0.85780073 |
| 65 | PDPK1 | 0.85240896 |
| 66 | IRAK4 | 0.82945194 |
| 67 | HCK | 0.82297497 |
| 68 | PDK2 | 0.79319105 |
| 69 | CSK | 0.79155083 |
| 70 | MAP3K11 | 0.77727131 |
| 71 | FLT3 | 0.77529450 |
| 72 | MAP3K1 | 0.76332345 |
| 73 | PDK1 | 0.76117356 |
| 74 | CAMKK1 | 0.74981749 |
| 75 | PIK3CG | 0.74632573 |
| 76 | MAPK12 | 0.73662726 |
| 77 | MAP3K8 | 0.73568400 |
| 78 | PAK2 | 0.72945198 |
| 79 | FES | 0.67714261 |
| 80 | SYK | 0.66567806 |
| 81 | KSR2 | 0.66294055 |
| 82 | BMPR2 | 0.65631872 |
| 83 | ARAF | 0.65500028 |
| 84 | EGFR | 0.65186660 |
| 85 | ABL1 | 0.64115953 |
| 86 | MAP3K13 | 0.63837747 |
| 87 | FGFR4 | 0.63735505 |
| 88 | PRKG2 | 0.63517327 |
| 89 | MAP2K1 | 0.62781748 |
| 90 | MAP3K2 | 0.61897662 |
| 91 | DAPK2 | 0.61561577 |
| 92 | MAP3K9 | 0.60337192 |
| 93 | ITK | 0.60270602 |
| 94 | LYN | 0.59770652 |
| 95 | CSF1R | 0.58600819 |
| 96 | PRKCQ | 0.57400541 |
| 97 | RPS6KA2 | 0.57119201 |
| 98 | ROCK1 | 0.56690614 |
| 99 | MAPK7 | 0.56298946 |
| 100 | PRKCD | 0.55097136 |
| 101 | GSK3A | 0.54942067 |
| 102 | TAOK3 | 0.54344908 |
| 103 | CAMK4 | 0.53731524 |
| 104 | PIM1 | 0.51890151 |
| 105 | CAMK1G | 0.51795318 |
| 106 | ACVR1B | 0.51747517 |
| 107 | NTRK1 | 0.51456691 |
| 108 | KSR1 | 0.49681362 |
| 109 | FGFR3 | 0.49369129 |
| 110 | FGFR1 | 0.49014906 |
| 111 | INSR | 0.48929954 |
| 112 | IKBKE | 0.48584281 |
| 113 | MAP3K12 | 0.46980982 |
| 114 | ROCK2 | 0.45528208 |
| 115 | TAOK2 | 0.45405244 |
| 116 | JAK2 | 0.44927425 |
| 117 | BCR | 0.44396627 |
| 118 | TGFBR1 | 0.43637119 |
| 119 | MAPKAPK2 | 0.42915174 |
| 120 | MARK3 | 0.42613239 |
| 121 | IGF1R | 0.42457476 |
| 122 | PKN1 | 0.40659531 |
| 123 | LATS2 | 0.39847622 |
| 124 | LCK | 0.39827759 |
| 125 | PRKCH | 0.39745965 |
| 126 | MAP3K5 | 0.39296792 |
| 127 | SRC | 0.38811073 |
| 128 | SGK3 | 0.36502192 |
| 129 | LIMK1 | 0.35559484 |
| 130 | MAPK4 | 0.35398314 |
| 131 | PAK3 | 0.35001433 |
| 132 | TESK2 | 0.34099940 |
| 133 | TAOK1 | 0.33885397 |
| 134 | PRKACG | 0.32325536 |
| 135 | EPHB2 | 0.31766278 |
| 136 | PRKAA2 | 0.31204361 |
| 137 | CAMK2G | 0.30658399 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Lysosome_Homo sapiens_hsa04142 | 3.80329894 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.50076738 |
| 3 | Malaria_Homo sapiens_hsa05144 | 2.75566629 |
| 4 | Phagosome_Homo sapiens_hsa04145 | 2.72855003 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.71710655 |
| 6 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.50856229 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.38174604 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.36523853 |
| 9 | * ECM-receptor interaction_Homo sapiens_hsa04512 | 2.20795205 |
| 10 | Legionellosis_Homo sapiens_hsa05134 | 1.91630511 |
| 11 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.88770013 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.86847157 |
| 13 | Tuberculosis_Homo sapiens_hsa05152 | 1.83463255 |
| 14 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.74100152 |
| 15 | Pertussis_Homo sapiens_hsa05133 | 1.72842070 |
| 16 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.70180717 |
| 17 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.62910653 |
| 18 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.61636892 |
| 19 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.56662197 |
| 20 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.54058470 |
| 21 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.51303211 |
| 22 | * Focal adhesion_Homo sapiens_hsa04510 | 1.50572890 |
| 23 | Amoebiasis_Homo sapiens_hsa05146 | 1.39044896 |
| 24 | Apoptosis_Homo sapiens_hsa04210 | 1.35101529 |
| 25 | Shigellosis_Homo sapiens_hsa05131 | 1.34522671 |
| 26 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.34474736 |
| 27 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.34285893 |
| 28 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.34155844 |
| 29 | Bladder cancer_Homo sapiens_hsa05219 | 1.32991928 |
| 30 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.30976652 |
| 31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.30445836 |
| 32 | Salmonella infection_Homo sapiens_hsa05132 | 1.28730274 |
| 33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.26528150 |
| 34 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.26059132 |
| 35 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.24160499 |
| 36 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.20079334 |
| 37 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.18086460 |
| 38 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.15129118 |
| 39 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.13458272 |
| 40 | Mineral absorption_Homo sapiens_hsa04978 | 1.09103727 |
| 41 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.08255673 |
| 42 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.07445584 |
| 43 | Allograft rejection_Homo sapiens_hsa05330 | 1.06904324 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.06550922 |
| 45 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.03278783 |
| 46 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.02320274 |
| 47 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.02161854 |
| 48 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.01819059 |
| 49 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.01672164 |
| 50 | Adherens junction_Homo sapiens_hsa04520 | 0.99938385 |
| 51 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.98430834 |
| 52 | Hepatitis B_Homo sapiens_hsa05161 | 0.97543281 |
| 53 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.93501885 |
| 54 | Measles_Homo sapiens_hsa05162 | 0.92798190 |
| 55 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.91965719 |
| 56 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.91388981 |
| 57 | Melanoma_Homo sapiens_hsa05218 | 0.90782256 |
| 58 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.90073067 |
| 59 | Influenza A_Homo sapiens_hsa05164 | 0.89980485 |
| 60 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.89129676 |
| 61 | Viral myocarditis_Homo sapiens_hsa05416 | 0.88531015 |
| 62 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.88157991 |
| 63 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.86412312 |
| 64 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.84039227 |
| 65 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.83207664 |
| 66 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.82739846 |
| 67 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.82661003 |
| 68 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.82637521 |
| 69 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.82434703 |
| 70 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.78861233 |
| 71 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.77108140 |
| 72 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.74501020 |
| 73 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.73323016 |
| 74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.73010922 |
| 75 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.72700669 |
| 76 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.70293082 |
| 77 | Hepatitis C_Homo sapiens_hsa05160 | 0.70066055 |
| 78 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.68078317 |
| 79 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.67829955 |
| 80 | Prion diseases_Homo sapiens_hsa05020 | 0.66172543 |
| 81 | Galactose metabolism_Homo sapiens_hsa00052 | 0.65367033 |
| 82 | * PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.64920409 |
| 83 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.64429176 |
| 84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64311887 |
| 85 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.60918552 |
| 86 | Prostate cancer_Homo sapiens_hsa05215 | 0.60005993 |
| 87 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59936478 |
| 88 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59587435 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.58957029 |
| 90 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.55774806 |
| 91 | Platelet activation_Homo sapiens_hsa04611 | 0.54250873 |
| 92 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.52358647 |
| 93 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.51506928 |
| 94 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.51290915 |
| 95 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.48434910 |
| 96 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.47713356 |
| 97 | Glioma_Homo sapiens_hsa05214 | 0.47191158 |
| 98 | Asthma_Homo sapiens_hsa05310 | 0.46735377 |
| 99 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.44636393 |
| 100 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.44542976 |
| 101 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.43249578 |
| 102 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.42907783 |
| 103 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41862313 |
| 104 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.41840816 |
| 105 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.40965822 |
| 106 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.40310996 |
| 107 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.39039858 |
| 108 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.39003558 |
| 109 | Bile secretion_Homo sapiens_hsa04976 | 0.38496148 |
| 110 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.38339851 |
| 111 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.36514585 |
| 112 | HTLV-I infection_Homo sapiens_hsa05166 | 0.36382724 |
| 113 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.35702633 |
| 114 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35690343 |
| 115 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.34704869 |
| 116 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.34539963 |
| 117 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.34436672 |
| 118 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.34294019 |
| 119 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33363274 |
| 120 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.32674167 |
| 121 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.32310591 |
| 122 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.27291906 |
| 123 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.25553728 |
| 124 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.25506755 |
| 125 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.23628385 |
| 126 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.20717247 |
| 127 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.20655576 |
| 128 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.16921899 |
| 129 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.15090866 |
| 130 | Renin secretion_Homo sapiens_hsa04924 | 0.14613443 |
| 131 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.14515308 |
| 132 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.14337847 |

